Clinical Trials Directory

Trials / Completed

CompletedNCT03530280

Effect of Pregabalin or Adductor Canal Block on Postoperative Analgesia

Effect of Pregabalin or Adductor Canal Block on Postoperative Analgesia After Arthroscopic Anterior Cruciate Ligament Reconstruction (ACL)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Ankara Diskapi Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

arthroscopically Anterior Cruciate Ligament Reconstruction (ACL) under spinal anesthesia were included in this study.

Detailed description

Patients who American Society of Anesthesiologists (ASA) classification I to II scheduled to undergo arthroscopically assisted ACL reconstructions under spinal anesthesia are included in this study. The first group is administered 150 mg oral pregabalin 1 hour before surgery and the postoperative sham block was performed with an ultrasound probe. The second group is the control group; patients in this group are administered a placebo capsule 1 hour before surgery and sham block was performed with an ultrasound probe.The third group is administered a placebo capsule 1 hour before surgery and postoperative adductor canal block is performed. All patients will be received postoperative a tramadol i.v. patient control analgesia device. At the end of 24 hours, the total amount of tramadol consumed by the patient will be recorded from the patient control analgesia. NRS score, white fast track, satisfaction will be questioned.

Conditions

Interventions

TypeNameDescription
DRUGpregabalin (lyrica)preoperative pregabalin and the postoperative sham block will perform.
DRUGPlacebo oral tabletThe preoperative placebo oral tablet and the postoperative sham block will perform.
DRUGadductor canal block including bupivacaineThe preoperative placebo oral tablet and adductor channel block including 10 mL of 0.25% bupivacaine with 5 μg/mL epinephrine

Timeline

Start date
2018-06-01
Primary completion
2018-10-01
Completion
2018-12-01
First posted
2018-05-21
Last updated
2019-10-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03530280. Inclusion in this directory is not an endorsement.